-transparent.png){kind=logo}
Detection of minimal residual myeloma cells by dual parameter analysis of DNA and cytoplasmic immunoglobulin. 1991
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
Second Department of Medicine, Kyoto Prefectural University of Medicine, Japan.
We demonstrated the utility of dual parameter analysis of DNA and cytoplasmic immunoglobulin for the detection of minimal residual myeloma cells in bone marrow and peripheral blood. This method is sensitive: even 0.1% of contaminating myeloma cells could be detected in peripheral blood of myeloma patients and in the model experiments using cell lines. This method is useful for the selection of patients undergoing high-dose chemotherapy and autologous blood stem cell transplantation.
Related Publications
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
January 1989,
American journal of clinical pathology,
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
December 2020,
Communications biology,
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
January 2018,
Seminars in hematology,
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
July 1987,
Science (New York, N.Y.),
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
September 1991,
British journal of haematology,
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
April 2018,
British journal of haematology,
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
January 2018,
Methods in molecular biology (Clifton, N.J.),
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
January 2019,
Frontiers in oncology,
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
January 2018,
Seminars in hematology,
C Shimazaki, and
H Gotoh, and
N Oku, and
T Inaba, and
S Murakami, and
N Oku, and
K Itoh, and
Y Ura, and
M Nakagawa, and
N Fujita
January 2015,
Nihon rinsho. Japanese journal of clinical medicine,
